PCN151 COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB FOR WOMEN WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER IN FRANCE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.347
https://www.valueinhealthjournal.com/article/S1098-3015(19)32725-1/fulltext
Title :
PCN151 COST-EFFECTIVENESS ANALYSIS OF ATEZOLIZUMAB FOR WOMEN WITH METASTATIC TRIPLE NEGATIVE BREAST CANCER IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32725-1&doi=10.1016/j.jval.2019.09.347
First page :
Section Title :
Open access? :
No
Section Order :
10281